New York Mets Photo Day

Former Cy Young winner takes powerful drug to aid his performance, no one cares

57 Comments

What if I were to tell you that there was a former Cy Young winner who was taking a controversial and powerful drug?

A drug that could prove dangerous to him in the long run and has been linked to organ damage? A drug that other players who have used it say gives them a feeling of invulnerability? A drug that experts are wary of for athletes because its long term effects when taken regularly aren’t known? A drug that is injected into the buttocks. A drug that, despite all of this, the player uses because it helps him recover from injury, soreness and fatigue and helps him get back on the field?

Why, I hope you would say nothing, because as David Lennon of Newsday reports, it’s totally OK in Major League Baseball:

When Johan Santana said last week that he received an injection of Toradol, a powerful anti-inflammatory medication, to stay on schedule for his Opening Day start, it hardly raised eyebrows in the clubhouse.

The reason? Santana is not the only one to benefit from the drug, and its use is more common than people might think.

There is not some logical bright line between what is a horrible, terrible PED and what is an acceptable drug in the world of sports. We like to pretend there is, but really, there isn’t. The biggest difference is that some are on a banned list and some are not, and that Santana and others use Toradol under a physicians care and guys who take banned drugs don’t.

Ultimately, these drugs are allowing players to do what their body would not naturally allow them to do. Here, it’s ignoring pain that could keep them from playing or certainly playing well.  With other drugs, it’s recovering from injury faster (HGH) or hitting a ball farther than they otherwise might (steroids). Either way, their performance is enhanced. Their natural state is altered by pharmaceuticals.

It would be awesome if we could approach some of the banned PEDs in this way and determine whether they present acceptable risks. Whether they serve a valuable purpose that, under a doctor’s care, don’t raise serious ethical concerns.  But we just don’t roll that way in professional sports these days.

Diamondbacks sign Jorge De La Rosa to minor league deal

ARLINGTON, TX - AUGUST 10:  Jorge De La Rosa #29 of the Colorado Rockies throws against the Texas Rangers in the first inning at Globe Life Park in Arlington on August 10, 2016 in Arlington, Texas.  (Photo by Ronald Martinez/Getty Images)
Getty Images
Leave a comment

The Diamondbacks have signed free agent left-hander Jorge De La Rosa to a minor league deal, per a team announcement on Sunday. The contract includes an invitation to spring training. Nick Piecoro of AZCentral.com adds that De La Rosa stands to make $2.25 million if he secures a spot on the major league roster, with up to $600,000 in incentives if he pitches out of the bullpen and up to $1 million in incentives if he pitches out of the starting rotation.

The 35-year-old is expected to compete for a bullpen role after spending the better part of a decade in the Rockies’ rotation. He capped a nine-year run with Colorado in 2016, finishing the year with a 5.51 ERA, 4.2 BB/9 and 7.3 SO/9 over 134 innings. Despite his struggles out of the rotation, he found limited success in a three-game stint in the bullpen, striking out 10 of 26 batters and holding the opposition to just three hits and one earned run in eight innings.

The veteran lefty is set to join a bullpen comprised of right-handers Randall Delgado, Jake Barrett and Fernando Rodney, along with a number of unproven candidates on similar minor league contracts. His age and command issues may be off-putting, but the promise he showed as a reliever should give the Diamondbacks some upside as they attempt to redeem a league-worst bullpen in 2017.

Josh Donaldson out 2-3 weeks with calf injury

TORONTO, CANADA - SEPTEMBER 13: Josh Donaldson #20 of the Toronto Blue Jays looks on from the top step of the dugout as he sits out his second straight game during MLB game action against the Tampa Bay Rays on September 13, 2016 at Rogers Centre in Toronto, Ontario, Canada. (Photo by Tom Szczerbowski/Getty Images)
Getty Images
Leave a comment

Blue Jays’ third baseman Josh Donaldson is expected to miss up to three weeks with a right calf strain, reports John Lott. Donaldson reportedly felt some discomfort in his calf during sprinting drills on Friday and was diagnosed with what looked like a mild strain after undergoing an MRI on Saturday. According to Lott, the 31-year-old is on crutches for the next few days and will likely miss 2-3 weeks of spring training.

Donaldson had a similar scare at the start of the 2016 season, when he limped out of the batter’s box during the Blue Jays’ first regular season road trip with a right calf strain. He returned to DH two days later, however, and was back on the field in less than a week’s time. Blue Jays’ GM Ross Atkins told MLB.com’s Corey Long that the two calf injuries are unrelated, and expects that Donaldson will recover in similar fashion this spring — well before Opening Day comes around.